Novel Postoperative Dropless Protocol for Micro-Incision Vitrectomy Surgery

To evaluate the outcomes of a novel postoperative dropless protocol for 25-gauge and 27-gauge micro-incision vitrectomy surgery (MIVS). The institutional review board approved a single-center, retrospective study. A total of 493 surgeries were identified, and 451 cases from 369 patients met eligibil...

Full description

Saved in:
Bibliographic Details
Published inOphthalmic surgery, lasers & imaging Vol. 52; no. 11; pp. 587 - 591
Main Authors Brown, Gordon T, Karth, Peter A, Hunter, Allan A
Format Journal Article
LanguageEnglish
Published United States Slack, Inc 01.11.2021
SLACK INCORPORATED
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To evaluate the outcomes of a novel postoperative dropless protocol for 25-gauge and 27-gauge micro-incision vitrectomy surgery (MIVS). The institutional review board approved a single-center, retrospective study. A total of 493 surgeries were identified, and 451 cases from 369 patients met eligibility criteria. Instead of pre- or postoperative drops, patients were given a novel postoperative dropless protocol consisting of subconjunctival injections of a 1:1 cefazolin:dexamethasone mix at each sclerotomy and intravitreally, and injection of posterior sub-Tenon's Kenalog. Primary outcome measure was cases of postoperative endophthalmitis. There was one presumed case of endophthalmitis. Anterior chamber paracentesis sample was negative for culture and Gram stain. For all patients, mean logMAR best-corrected visual acuity improved from 0.65 (±0.69) to 0.57 (±0.61) postoperatively ( = 0.004). Mean intraocular pressure increased from 14.5 (±4.3) to 15.5 (±4.8) postoperatively ( < 0.001). Mean follow-up was 96 days. This novel postoperative dropless protocol could potentially be a convenient alternative to topical eye drops for patients undergoing MIVS, but further study is required to establish its safety. .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2325-8160
2325-8179
DOI:10.3928/23258160-20211014-01